Paid Clinical Trials in Newark, DE
As of August 2026, 145 paid clinical trials are recruiting in Newark, Delaware. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Newark offers studies at sites including Helen F Graham Cancer Center for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Lung Non-Small Cell Carcinoma, Multiple Myeloma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Newark
Trials by drug in Newark
Filter results
139 clinical trials
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Invasive Preeclampsia Screening and Biobank
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Study of SGR-1505 in Mature B-Cell Neoplasms
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
Autologous Adipose Cells Therapy
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Breathing Patterns in Infants Before and After Extubation
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Top Research Study Locations in Newark
Researchers run research studies in Newark, DE at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Helen F Graham Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Stage IVB Prostate Cancer AJCC v8 | 62 |
| Medical Oncology Hematology Consultants PA | Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Anatomic Stage IIIA Breast Cancer AJCC v8 | 59 |
| Christiana Care Health System-Christiana Hospital | Stage IV Pancreatic Cancer AJCC v8, Malignant Digestive System Neoplasm, Malignant Solid Neoplasm | 26 |
| University of Delaware | Hypertension, Major Depressive Disorder, Parkinson Disease | 15 |
| Medical Oncology Hematology Consultants | Advanced Malignant Neoplasm, Advanced Solid Tumor, Breast Cancer | 7 |
| Christiana Care | Advanced Colorectal Cancer, Autism Spectrum Disorder, Blood Loss, Surgical | 6 |
| Medical Oncology Hematology Consultants, PA | Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Leukemia, Myeloid, Acute | 6 |
| Christiana Care Health Services | Advanced Cancer, Advanced or Metastatic Solid Tumor, Cardiovascular Diseases | 4 |
| Christiana Care Health Services, Inc. | Acute Myocardial Infarction, Induction of Labor Affected Fetus / Newborn, LE ALI | 3 |
| ChristianaCare Health System | Abnormal Uterine Bleeding, Unspecified, Adenomyosis of Uterus, Adnexal Diseases | 2 |
| ChristianaCare Helen F Graham Cancer Center and Research Institute | Carcinoma, Non-Small-Cell Lung, Multiple Myeloma | 2 |
| Medical Oncology Hematology Consultants Helen F Graham Cancer Center | Metastatic Castration-resistant Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC) | 2 |
| Medical Oncology Hematology Consultants (MOHC) | Breast Neoplasms, Lymphoma, Large B-Cell, Diffuse | 2 |
| Christiana Care Health System - Newark | Solid Tumor | 1 |
| Christiana Care Hospital | Pulmonary Embolism | 1 |
| Christiana Care Hospital - Helen F Graham Cancer Center | ALK-Positive Large B-Cell Lymphoma, Burkitt Lymphoma, Chronic Lymphocytic Leukemia | 1 |
| Christiana Care/New Castle County EMS | Congestive Heart Failure(CHF), Pulmonary Edema | 1 |
| Christiana Hospital | Status Epilepticus | 1 |
| Christiana Surgicenter | Lumbar Spinal Stenosis | 1 |
| ChristianaCare | Delivery Room Resuscitation, Implementation Research, Infant, Newborn | 1 |
| ChristianaCare Health Services, Inc. | PreTerm Neonate, Respiratory Distress Syndrome (RDS) | 1 |
| ChristianaCare-Helen F. Graham Cancer Center & Research Institute | Breast Cancer Screening, Colon Cancer Screening, Genetics Predisposition | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Delaware Center for Maternal and Fetal Medicine | Preeclampsia (PE) | 1 |
| Delaware Outpatient Center for Surgery | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Newark (2026)
Recruiting trials in Newark grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (93 active studies)
- Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial · Phase 3 · National Cancer Institute (NCI)
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
Neurology & pain (7 active studies)
- Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy · Phase 4 · Christiana Care Health Services
- Pain and Split-belt Motor Learning in Older Adults · University of Delaware
Cardiovascular (4 active studies)
- Evaluating the Use of Prehospital Lung Ultrasound in EMS: A Multicenter Pilot Study · Rutgers, The State University of New Jersey
- Examining the Circadian Timing Effects of the Hypotensive Response to Exercise · Freda Patterson
Pediatric (2 active studies)
- Supraglottic Airway for Resuscitation Trial · Children's Hospital of Philadelphia
- Study of SGR-1505 in Mature B-Cell Neoplasms · Phase 1 · Schrödinger, Inc.
Vaccines (1 active study)
Common conditions studied in Newark
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Breast Cancer (5 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
- Multiple Myeloma (4 active studies)
- Stage IVB Prostate Cancer AJCC v8 (4 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (3 active studies)
Leading research sponsors in Newark
- National Cancer Institute (NCI)
- University of Delaware
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Newark?
There are approximately 145 recruiting clinical trials in Newark, Delaware listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Newark pay participants?
Most recruiting trials in Newark compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Newark?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Newark?
The most common conditions under active study in Newark include Anatomic Stage II Breast Cancer AJCC v8 (5), Breast Cancer (5), Lung Non-Small Cell Carcinoma (4), Multiple Myeloma (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Newark?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Newark on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Newark?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Newark?
Recruiting research sites in Newark include Helen F Graham Cancer Center, Medical Oncology Hematology Consultants PA, Christiana Care Health System-Christiana Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Newark right now?
The largest active categories in Newark are Cancer & tumors (93), Neurology & pain (7), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.